Welcome to Insider Healthcare. I’m healthcare editor Leah Rosenbaum, and today in healthcare news:
- We asked the leaders of billion-dollar healthcare systems what new technologies are overhyped;
- 5am Ventures is raising two new biotech funds;
- What we do — and don’t — know about the new Omicron COVID-19 variant.
Automation, telehealth and augmented reality: We asked leaders at billion-dollar health systems what tech is currently overhyped.
- Health systems are testing new tech to see what’s worth future investment.
- But some buzzy technologies aren’t likely to take off soon, leaders of billion-dollar systems tell us.
- Automation, augmented reality and even telehealth might be getting too much hype, they tell Insider.
- 5AM Ventures is raising $US750 ($AU1,053) million for two new funds for early- and late-stage investments.
- 5AM is one of the longest-running VCs focused on biotech and creates many of its own startups.
- Biotech VCs have been raising record amounts, but a top analyst says that could change in 2022.
The new coronavirus variant Omicron raises red flags among scientists — but there are more mysteries than answers about its public threat
- The WHO labeled a new coronavirus variant, Omicron, a “variant of concern” on Friday.
- The B.1.1.529 variant contains hallmarks of being more transmissible or dangerous than other strains.
- But scientists have just begun to examine Omicron’s threat, including its unfamiliar mutations.
More stories we’re reading:
- 1 chart shows how quickly a booster shot can improve immunity, with some extra protection in just a few days (Insider)
- Pfizer is claiming an employee stole COVID-19 vaccine secrets when leaving the company (Reuters)
- Alzheimer’s nasal vaccine to enter human trials for the first time, spurring renewed hope for preventing the disease (Insider)
- Restrictive abortion laws in Texas threaten women with risky pregnancies (The New York Times)